Meta is moving to capture a demographic that represents billions of potential customers: people who wear glasses for vision correction. According to reporting by Bloomberg, the company plans to debut two new Ray-Ban AI glasses models next week specifically designed for prescription wearers, marking the first time Meta and its manufacturing partner EssilorLuxottica have introduced glasses engineered from the ground up for this population.
While prescription lenses have been available as add-ons to Meta's existing Ray-Ban AI glasses, the coming models represent a shift in strategy. The new designs, reportedly codenamed Scriber and Blazer, will be sold through traditional eyewear retail channels rather than direct-to-consumer platforms alone. Two distinct styles, rectangular and rounded frames, suggest Meta is testing multiple approaches to appeal to different face shapes and preferences within the prescription-wearing population.
The rationale is straightforward. Meta CEO Mark Zuckerberg has repeatedly signalled in investor calls that "billions of people wear glasses or contacts for vision correction," characterising this market as fundamental to the company's long-term glasses strategy. In Zuckerberg's framing, it would be difficult to imagine a world where most glasses people wear are not AI-enabled within the next several years. Ignoring the prescription market would mean leaving the door open to competitors.
A market with momentum but distribution challenges
Meta's broader AI glasses business is gaining genuine traction. EssilorLuxottica reported sales of over 7 million AI glasses in 2025, up from 2 million sold in 2023 and 2024 combined. Meta's share of the global smart glasses market rose to 73 per cent in the first half of 2025, with global smart glasses shipments growing 110 per cent year-on-year in that period.
Yet scale remains uneven. More than two million Ray-Ban Meta units sold in the first year and a half after launch, but achieving mainstream adoption outside early-adopter circles requires reaching people who may not seek out new technology proactively. Those who need prescription correction represent a captive audience; they purchase glasses regularly, often through established optometry and retail channels. Placing AI glasses directly into those distribution networks removes friction.
The current approach has worked for the tech-forward minority. Existing Ray-Ban Meta glasses support prescription lenses for prescriptions within the -6.00 to +4.00 range, available through Meta's direct store and certified retailers. But retrofitting an off-the-shelf frame with prescription lenses involves extra steps and higher costs. A purpose-built model, fitted at an optometrist's office or sold at LensCrafters, simplifies the purchase decision for millions of people who already view glasses shopping as a routine errand.
Distribution as distribution, not afterthought
Meta's move reflects hard lessons from the broader wearable history. Early smart eyewear like Google Glass struggled partly because it prioritised cutting-edge technology over style and social acceptance. Meta solved the style problem by partnering with Ray-Ban, a brand that carries decades of consumer trust and fashion credibility. But design excellence means little if the product remains difficult to buy.
The move to traditional prescription channels also signals confidence in the product's stability. Meta reported overwhelming demand for its new Ray-Ban Display AI glasses, leading to a supply shortage and delayed international rollout. Rather than rushing international expansion, the company is consolidating its US position and preparing to serve prescription wearers through established optometry networks. This is disciplined capital allocation: expand the addressable market before chasing geographic growth.
What remains unclear is whether the new models will include displays, as featured in the premium Meta Ray-Ban Display glasses priced at USD$799. The Federal Communications Commission filings describing the devices as production units suggest they are close to launch, but reports indicate the prescription models may lack the in-lens display that distinguishes Meta's premium offering. If true, these glasses would function as audio and AI assistants without the visual component, positioning them as an accessible entry point rather than a full augmented-reality experience.
That positioning, if accurate, makes economic sense. Mass-market adoption of prescription AI glasses requires a price point and complexity level accessible to the average consumer. A camera and speaker package from an established eyewear brand might achieve what years of bleeding-edge hardware could not: genuine mainstream traction. The real test arrives in weeks when Meta reveals the models, their pricing, and their feature set.